Southern Adelaide Diabetes and Endocrine Services

Southern Adelaide Local Health Network

Kidney Diseases

Diabetic Nephropathies

Diabetes Mellitus

Type 1 Diabetes Mellitus

Diabetic Retinopathy

Retinal Diseases

Fenofibrate

University of Sydney

condition

allSponsorName

Mylan

gender

Male

Female

overallStatus

Recruiting

Not yet recruiting

Active, not recruiting

Enrolling by invitation

Completed

Terminated

Withdrawn

Suspended

Unknown

type

Interventional

Observational

Expanded Access

phase

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Not Applicable

funderTypes

Industry

Other U.S. Federal agency

All others

ageGroup

Child (birth-17)

Adult (18-64)

Older Adult (65+)

The purpose of this study is to evaluate the potential benefits of 145 mg of daily fenofibrate in adults with type 1 diabetes mellitus and pre-existing non-proliferative diabetic retinopathy.

The Fenofibrate And Microvascular Events in Type 1 Diabetes Eye.

Southern Adelaide Local Health Network | Southern Adelaide Diabetes and Endocrine Services

Site insights

Work at this site?

Active trials

The Fenofibrate And Microvascular Events in Type 1 Diabetes Eye. (FAME 1 EYE)

Trial sponsors